SCHEMBL24317422

SCHEMBL24317422

CCOC1CCC(N2CC(OC)C2)CC1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.32
HSD11B1 P28845 1/20 0.31
CCR2 P41597 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26619666 0.85 IRAK4 (0.35) IRAK4
SCHEMBL24921073 0.85
SCHEMBL24315775 0.80 HSD11B1 (0.31) HSD11B1
SCHEMBL24995531 0.80 HSD11B1 (0.31) HSD11B1
SCHEMBL20727170 0.80 KDM4E (0.37) HSD11B1
SCHEMBL18361629 0.78 ALDH1A1 (0.33)
SCHEMBL8444083 0.78 DPP4 (0.37)
SCHEMBL24315776 0.78 IRAK4 (0.32) IRAK4
SCHEMBL24718088 0.77 KDM4E (0.33) IRAK4
SCHEMBL25921408 0.77 KDM4E (0.33) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed